| Q50868148 | Autonomic Nervous System in Pulmonary Arterial Hypertension: Time to Rest and Digest. |
| Q94503331 | Bisoprolol therapy does not reduce right ventricular sympathetic activity in pulmonary arterial hypertension patients |
| Q100391115 | CD248 as a novel therapeutic target in pulmonary arterial hypertension |
| Q58558077 | Corticosterone and pyridostigmine/DEET exposure attenuate peripheral cytokine expression: Supporting a dominant role for neuroinflammation in a mouse model of Gulf War Illness |
| Q99594675 | Distribution and relative expression of vasoactive receptors on arteries |
| Q59129600 | Electrical Vagal Nerve Stimulation Ameliorates Pulmonary Vascular Remodeling and Improves Survival in Rats With Severe Pulmonary Arterial Hypertension |
| Q92475426 | Heart Rhythm Complexity Predicts Long-Term Cardiovascular Outcomes in Peritoneal Dialysis Patients: A Prospective Cohort Study |
| Q89543096 | Influence of riociguat treatment on pulmonary arterial hypertension : A meta-analysis of randomized controlled trials |
| Q58593702 | Insights on the epigenetic mechanisms underlying pulmonary arterial hypertension |
| Q90355926 | RNA sequencing analysis of monocrotaline-induced PAH reveals dysregulated chemokine and neuroactive ligand receptor pathways |
| Q92086109 | Revealing the pathogenic changes of PAH based on multiomics characteristics |
| Q60950964 | The Role of G Protein-Coupled Receptors in the Right Ventricle in Pulmonary Hypertension |
| Q60044241 | Total serum cholinesterase activity predicts hemodynamic changes during exercise and associates with cardiac troponin detection in a sex-dependent manner |
| Q64890066 | Transection of the cervical sympathetic trunk inhibits the progression of pulmonary arterial hypertension via ERK-1/2 Signalling. |
| Q59136747 | Vagal Nerve Stimulation for Pulmonary Hypertension: Some Promise, Some Skepticism |